Physician profile
Jade E Russell
NPI 1801406335
$572.06
in general payments reported to CMS, 2019-2025
10 companies · $32.09 in 2025
The $32.09 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $226 · 2023: $157 · 2024: $22.90 · 2025: $32.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $212.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $105.57 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Biohaven Pharmaceuticals, INC. | $91.18 | 2021 | |
| Abbvie INC. | $67.28 | 2022 | |
| Lilly USA, LLC | $66.34 | 2023 | Mounjaro |
| Ibsa Pharma INC. | $61.24 | 2021-2025 | Flector, Licart, Tirosint |
| Mayne Pharma Commercial LLC | $55.08 | 2022 | |
| Jazz Pharmaceuticals INC. | $44.51 | 2021-2022 | |
| Bio Products Laboratory USA, INC. | $31.79 | 2022-2023 | Coagadex, Gammaplex |
| Acella Pharmaceuticals, LLC | $27.86 | 2021-2025 | NP Thyroid 60 |
| Exact Sciences Corporation | $21.21 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Russell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.